Cervical Cancer :: Cervarix, GSK’s cervical cancer vaccine, approved in Europe
GlaxoSmithKline (GSK) announced that the European Commission has granted a marketing authorisation for its cervical cancer vaccine, Cervarix for all 27 European member states.